BLA Regulatory
BLA Regulatory offers expert FDA regulatory consulting and U.S. Agent representation for drug and medical device companies. They facilitate IND filings, clinical trial strategy, and navigate complex regulatory pathways.
BLA Regulatory is a specialized consulting firm providing comprehensive regulatory services for drug and medical device companies seeking to enter or operate within the U.S. market. With extensive experience in IND filings, clinical trial registration, and strategy development, they act as a crucial U.S. Agent, facilitating interaction with the FDA on behalf of foreign sponsors. Their expertise spans the entire product lifecycle, from initial research and nonclinical development through submission, approval, and post-market maintenance. BLA Regulatory excels in formalizing meetings with regulatory agencies, providing critical regulatory insight, and ensuring operational efficiency. They offer tailored end-to-end approaches, translating complex regulatory requirements into actionable plans to expedite product development and market entry. BLA Regulatory's services are designed to support companies, particularly startups and small biotechs, in navigating the intricacies of FDA compliance. They offer guidance on medical device classification through 513(g) requests, develop robust IND/CTA strategies with NDA/BLA submissions in mind, and provide essential support for clinical trial recruitment and registration. Their team of FDA-experienced experts, industry leaders, and regulatory professionals ensures clients receive competent and reliable support to achieve their development and commercialization goals.
About
**Who they are**
BLA Regulatory provides expert FDA regulatory consulting and U.S. Agent representation for drug and medical device companies. They facilitate IND filings, clinical trial strategy, and navigate complex regulatory pathways.
**Expertise & scope**
* U.S. Agent Representation: Facilitates interaction with the FDA for foreign sponsors, offering regulatory insight and operational efficiency beyond basic communication.
* IND Filing & Maintenance: Assists in compiling robust data sets to support Investigational New Drug applications for advancing new drugs into human trials.
* Health Authority Meetings: Organizes and advises on formal meetings with regulatory agencies for drugs in development and post-marketing support.
* Strategy Development: Creates tailored end-to-end approaches for product development, from research to submission and maintenance, focusing on IND/CTA strategy with NDA/BLA in sight.
* Regulatory Gap Analysis: Conducts logical and scientific reviews of available information to forecast product success and inform discussions with regulatory agencies.
* Medical Writing: Develops quality regulatory, clinical, and scientific documents, adhering to guidelines such as ICH-GCP, FDA, and EMA, for eCTD and CTD modules.
**Reputation / proof points**
* Functions as an extension of the client's internal team, ensuring compliance throughout the product development and marketing program.
BLA Regulatory provides expert FDA regulatory consulting and U.S. Agent representation for drug and medical device companies. They facilitate IND filings, clinical trial strategy, and navigate complex regulatory pathways.
**Expertise & scope**
* U.S. Agent Representation: Facilitates interaction with the FDA for foreign sponsors, offering regulatory insight and operational efficiency beyond basic communication.
* IND Filing & Maintenance: Assists in compiling robust data sets to support Investigational New Drug applications for advancing new drugs into human trials.
* Health Authority Meetings: Organizes and advises on formal meetings with regulatory agencies for drugs in development and post-marketing support.
* Strategy Development: Creates tailored end-to-end approaches for product development, from research to submission and maintenance, focusing on IND/CTA strategy with NDA/BLA in sight.
* Regulatory Gap Analysis: Conducts logical and scientific reviews of available information to forecast product success and inform discussions with regulatory agencies.
* Medical Writing: Develops quality regulatory, clinical, and scientific documents, adhering to guidelines such as ICH-GCP, FDA, and EMA, for eCTD and CTD modules.
**Reputation / proof points**
* Functions as an extension of the client's internal team, ensuring compliance throughout the product development and marketing program.
Additional information
BLA Regulatory emphasizes a tailored, end-to-end approach to guide clients through the entire drug development cycle. Their services can commence from product research and extend through nonclinical and clinical development, submission, approval, and post-approval maintenance. As a U.S. FDA Agent, they facilitate various meetings with regulatory agencies, including Pre-IND, pre/end-of-phase, and advisory meetings. Their expertise aims to translate regulatory requirements into actionable plans, leveraging deep industry knowledge and regulatory intelligence to ensure product development and marketing programs meet compliance standards.
Key Highlights
-
Offers U.S. Agent Representation to facilitate interaction with the FDA for foreign sponsors.
Source
“Foreign sponsors of drug applications who want to conduct business in the United States need an authorized U.S. Agent to interact with the FDA on their behalf.”
-
Provides comprehensive IND Filing & Maintenance services to support advancing new drugs into human trials.
Source
“BLA Regulatory works with our clients, the sponsors, to present the best case to the regulators by compiling a robust data set describing how the drug is made and determined to be pure and potent...”
-
Specializes in Health Authority Meetings, including Pre-IND, pre/end-of-phase, and advisory meetings.
Source
“Our past interactions with the FDA include teleconferences, face-to-face meetings, and written correspondences with a wide array of FDA offices and divisions.”
-
Develops tailored regulatory strategies from product research through submission and maintenance.
Source
“BLA Regulatory provides comprehensive strategy and operations services to guide you through every step of the regulatory process.”
-
Conducts Regulatory Gap Analysis to forecast product success and inform agency discussions.
Source
“A gap analysis is a powerful tool that can be used to forecast a product’s success. It involves a logical and scientific review of available information and forms the basis for preliminary discussions with regulatory agencies.”
-
Expert Medical Writing services for regulatory, clinical, and scientific documents, adhering to ICH-GCP, FDA, and EMA guidelines.
Source
“BLA Regulatory has a comprehensive understanding of various regulatory guidelines such as ICH-GCP, FDA, and EMA.”
Certifications & Trust Signals
-
Established presence with a physical address in Gaithersburg, MD.
Source
“610 Professional Dr. Suite 225 Gaithersburg, MD 20879”
Buyer Snapshot
Best for
- Foreign sponsors needing FDA U.S. Agent representation
- Companies navigating IND filings and clinical trial strategy
- Drug and medical device companies requiring regulatory consulting
How engagement typically works
- Acts as an extension of the client's internal team
- Provides tailored, end-to-end regulatory strategies
Typical deliverables
- U.S. Agent representation services
- IND filing and maintenance support
- Health authority meeting facilitation
- Regulatory strategy development
- Gap analysis reports
- Medical writing services
Good to know
- Best when requiring expert guidance on complex FDA regulatory pathways.
HQ:
Gaithersburg, US
Languages:
English
Timezones:
America/New_York
Claim status:
Listed
Services & Capabilities
Best FDA US Agent Services | Compare & Get Quotes
Jurisdictions:
US
Countries:
US
Industries:
Medical devices, Drugs
Portfolio:
6-25, 26-100, 100+
Onboarding time:
2–7 days
Pricing model:
Retainer
Starting from:
USD 1,700
Included services:
FDA communications handling, Establishment registration support, Product listing assistance, Regulatory submission support, Compliance consulting
Product Type:
drugs
Service Types:
US Agent Services, FDA Registration/Listing Support, FDA Submissions (510(k), PMA, IDE, etc.), Regulatory Consulting
Additional us_agent_fda Details
Product Types
Drugs, Medical Devices
Registration Support
Implied through U.S. Agent services for foreign sponsors.
Recall Support
No explicit mention
Inspection Support
No explicit mention
Emergency Contact24x7
No explicit mention
US Entity State
MD
Onboarding Steps
No explicit mention
⚡ Instant booking available
Appoint a Vetted FDA U.S. Agent in 2 Minutes
Compare BLA Regulatory and other vetted providers — instant pricing, no RFQ needed.
